Wolf, J., Heist, R., Kim, T. M., Nishio, M., Dooms, C., Kanthala, R. R., Leo, E., Giorgetti, E., Wang, Y., Mardjuadi, F. I. and Cortot, A. (2022). Efficacy and safety of capmatinib plus spartalizumab in treatment-naive patients with advanced NSCLC harboring MET exon 14 skipping mutation. Ann. Oncol., 33 (7). S. S1007 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Wolf, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Heist, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kim, T. M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Nishio, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dooms, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kanthala, R. R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Leo, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Giorgetti, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wang, Y.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mardjuadi, F. I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cortot, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-693180
DOI: 10.1016/j.annonc.2022.07.1120
Journal or Publication Title: Ann. Oncol.
Volume: 33
Number: 7
Page Range: S. S1007 - 2
Date: 2022
Publisher: ELSEVIER
Place of Publication: AMSTERDAM
ISSN: 1569-8041
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/69318

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item